Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Biomacromolecules|February 15, 2018
Diels-Alder Click-Cross-Linked Hydrogels with Increased Reactivity Enable 3D Cell EncapsulationLaura J Smith, S Maryamdokht Taimoory, Roger Y Tam, et al.
Nature Biotechnology|September 22, 2014
Generation of the epicardial lineage from human pluripotent stem cellsAlec D Witty, Anton Mihic, Roger Y Tam, et al.
Biochimie|September 3, 2013
Modulation of bone marrow mesenchymal stem cell secretome by ECM-like hydrogelsNuno A Silva, Joana Moreira, Silvina Ribeiro-Samy, et al.
Biomaterials|August 10, 2016
Combination of a peptide-modified gellan gum hydrogel with cell therapy in a lumbar spinal cord injury animal modelEduardo D Gomes, Sofia S Mendes, Hugo Leite-Almeida, et al.
Organic & Biomolecular Chemistry|August 17, 2016
6-Bromo-7-hydroxy-3-methylcoumarin (mBhc) is an efficient multi-photon labile protecting group for thiol caging and three-dimensional chemical patterningM Mohsen Mahmoodi, Stephanie A Fisher, Roger Y Tam, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 28, 2018
Rationally Designed 3D Hydrogels Model Invasive Lung Diseases Enabling High-Content Drug ScreeningRoger Y Tam, Julien Yockell-Lelièvre, Laura J Smith, et al.
Glycobiology|August 20, 2011
Inhibiting ice recrystallization and optimization of cell viability after cryopreservationJennifer L Chaytor, Jacqueline M Tokarew, Luke K Wu, et al.
Advanced Materials (Deerfield Beach, Fla.)|July 20, 2019
Benchmarking to the Gold Standard: Hyaluronan-Oxime Hydrogels Recapitulate Xenograft Models with In Vitro Breast Cancer Spheroid CultureAlexander E G Baker, Laura C Bahlmann, Roger Y Tam, et al.
Stem Cell Research & Therapy|February 13, 2021
Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cellJonathan Gobin, Gauri Muradia, Jelica Mehic, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 3, 2023
Tissue-Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC InhibitionAdam Pietrobon, Julien Yockell-Lelièvre, Nicole Melong, et al.
Pageof 4